Find a trial

WOMBAT / ANZUP 2201

Evaluating the efficacy of bipolar androgen therapy in extending metastasis-free survival in patients with M0 castrate-resistant prostate cancer with prostate specific antigen progression but not radiological or clinical progression on darolutamide

Locations Chermside

Diagnosis Prostate cancer

NIAGARA-2 / D933RC00002

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/​Cisplatin in Patients With Muscle-invasive Bladder Cancer

Locations Chermside

Diagnosis Bladder cancer

SGNDV-001

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Locations Chermside

Diagnosis Urotherlial cancer

ZN-c3-005

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (DENALI)

Locations Chermside

Diagnosis Ovarian cancer

IMGN853-0425

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

Locations Chermside

Diagnosis Ovarian cancer

HERTHENA-PanTumor01 / U31402-277

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Locations Townsville, Hobart, Chermside

Diagnosis Advanced solid tumours